Frank J Steemers

USPTO Granted Patents = 47 (Patent Applications = 36)

CIPO Patents = 7 (Patent Applications = 17)

EPO Patents = 31 (Patent Applications = 48)

Average Co-Inventor Count = 4.1

ph-index = 9

Forward Citations = 479(Granted Patents)

Location History:

San Diego, CA (US) (2007 - 2024)
Encinitas, CA (US) (2010 - 2024)

Company Filing History:

Illumina Cambridge Limited

University of Washington

patents

5. 1 out of 509

Oregon Health & Science University

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Nucleic Acid Sequencing

DNA Processing

Biomolecule Tagging

Single Cell Sequencing

Transposase Compositions

Genomic Connectivity

Polynucleotide Enrichment

Error Suppression

High-Throughput Sequencing

Combinatorial Indexing

Amplification of Nucleic Acids

Cellular Component Analysis

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12416002 - Analysis system for orthogonal access to and tagging of biomolecules in cellular compartments (2025-09-16),

2. 12371690 - Methods and compositions using one-sided transposition (2025-07-29),

3. 12297565 - Methods and means for preparing a library for sequencing (2025-05-13),

4. 12297221 - Functionalization and purification of molecules by reversible group exchange (2025-05-13),

5. 12280350 - Compositions and methods for the amplification of nucleic acids (2025-04-21),

6. 12180468 - Transposase compositions for reduction of insertion bias (2024-12-31),

7. 12104281 - Analysis of multiple analytes using a single assay (2024-10-01),

8. 11999945 - Modulating polymer beads for DNA processing (2024-06-04),

9. 11993772 - Linking sequence reads using paired code tags (2024-05-28),

10. 11981891 - High-throughput single-cell sequencing with reduced amplification bias (2024-05-14),

11. 11965158 - Methods and compositions using one-sided transposition (2024-04-23),

12. 11873480 - Contiguity preserving transposition (2024-01-16),

13. 11866777 - Error suppression in sequenced DNA fragments using redundant reads with unique molecular indices (UMIS) (2024-01-09),

14. 11760994 - Separating polynucleotide fragments (2023-09-19),

15. 11760772 - Functionalization and purification of molecules by reversible group exchange (2023-09-19),

Title: The Inventive Journey of Frank J Steemers

Introduction:

Frank J Steemers, a prolific inventor based in Encinitas, CA (US), is a visionary in the field of DNA processing and sequencing technologies. With an impressive portfolio of 40 patents to his name, Steemers continues to push the boundaries of innovation in the scientific community.

Latest Patents:

Steemers' latest patents showcase his expertise in modulating polymer beads for DNA processing and linking sequence reads using paired code tags. The former focuses on the encapsulation of biomolecules within beads to facilitate sequential reactions, while the latter introduces artificial transposon sequences with unique code tags for analyzing target nucleic acids.

Career Highlights:

During his career, Frank J Steemers has made significant contributions to renowned companies such as Illumina Corporation and Illumina Cambridge Limited. His innovative solutions have paved the way for advancements in genetic research and molecular biology, solidifying his reputation as a trailblazer in the industry.

Collaborations:

Steemers has collaborated closely with esteemed colleagues, including Kevin L Gunderson and Sasan Amini, who have shared his passion for groundbreaking scientific discoveries. Together, they have worked on cutting-edge projects that have revolutionized the field of genomics and personalized medicine.

Conclusion:

In conclusion, Frank J Steemers stands as a beacon of ingenuity and creativity in the realm of DNA processing and sequencing. His dedication to innovation, coupled with his relentless pursuit of excellence, continues to inspire the next generation of inventors and researchers in the ever-evolving landscape of biotechnology.

This text is generated by artificial intelligence and may not be accurate.